Evogene announces completion of transaction for the sale of lavie bio's activity to icl

Rehovot, israel , july 8, 2025 /prnewswire/ -- evogene ltd.  (nasdaq: evgn) (tase: evgn), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of the activities and assets of its ag-biologicals subsidiary, lavie bio ltd.
ICL Ratings Summary
ICL Quant Ranking